SOUTH ASIAN UNIVERSITY

A University Established by SAARC Nations

SOUTH ASIAN UNIVERSITY

A University established by SAARC Nations

FLSB

Faculty of Life Sciences and Biotechnology

Molecular Medicine Lab

Prof. Senthil Kumar Venugopal
Principal Investigator

Research Interest

Focus of our Research

Our laboratory is primarily studying the molecular dynamics underlying the pathophysiology of liver. We aim to translate these discoveries into better diagnostic and therapeutic strategies for better outcome for patients with liver disease.

  1. Hepatitis B Virus (Their Role in chronic liver disease)
  2. Non-coding RNAs (Their regulation in liver function)
  3. Liver Regeneration (Molecular control of regenerative capacity)
  4. MASLD / MetALD (Molecular signatures of fatty liver disease)

The Biology Driving Our Questions

The liver is a multifunctional organ responsible for metabolism, biosynthesis, secretion and detoxification. Uniquely, it can regenerate through cell proliferation after injury but when cell loss outpaces regeneration due to viral infection, dysbalance in the diet intake, etc., chronic liver injury occurs. Depending on the insult, the injury progresses towards fibrosis, cirrhosis, or hepatocellular carcinoma. All of these processes are tightly controlled by various genes. We work on elucidating the mechanisms controlling the chronic liver injury.

  1. Healthy Liver (Metabolism, biosynthesis, secretion & detoxification, with a unique capacity to regenerate after hepatectomy or injury.)
  2. Injury & Imbalance (Alcohol, fatty diet or viral infection (HBV/HCV) damage hepatocytes faster than they can regenerate.)
  3. Fatty Liver → Steatohepatitis (Fat accumulates; oxidative stress and inflammation accelerate injury and activate stellate cells.)
  4. Fibrosis → Cirrhosis → Cancer (Persistent injury drives fibrosis, cirrhosis and, in many cases, hepatocellular carcinoma.)

Current Lab members

Gopal Sharma
PhD Student (2023–present) – Bhutan

I study metabolic liver disease arising from metabolic dysfunction and moderate alcohol consumption, with an emphasis on disease modelling and the discovery and characterization of metabolic biomarkers. Integrates animal and cellular disease models with clinical data to understand disease mechanisms and identify biomarkers of diagnostic relevance.
Tannavi
PhD Student (2024–present) – India

Working on Metabolic Dysfunction-Associated Alcoholic Liver Disease, focusing on early protein biomarkers associated with disease onset and progression to improve diagnosis and therapy. Integrates animal models, cell lines and clinical samples to identify and validate novel diagnostic biomarkers.
Amardeep Ashish
PhD Student (2025–present) – India

Studies how gut–liver communication contributes to the development and progression of MetALD, particularly through alterations in intestinal permeability, inflammation and hepatic metabolism, using animal models and advanced in vitro approaches including gut–liver co-culture systems.
Dr. Amrendra Kumar Sah
Project Research Scientist–II – Nepal

Currently developing a field-deployable diagnostic kit using CRISPR for the detection of hepatitis B and hepatitis C virus.

Alumni

Kishor Pant
Ph.D. student (2013-18) - Nepal
Title of the Thesis:
“Study of the role of butyrate, a short-chain fatty acid, in modulating HBV replication and hepatocellular carcinoma”

Senior Scientist (2023–present), previously Postdoctoral Researcher (2018–23), The Hormel Institute, University of Minnesota, USA
Parul Gupta
Ph.D. student (2014-19) – India
Title of the Thesis:
"Role of Augmenter of Liver Regeneration (ALR) in Liver Regeneration"

Project Manager, Business Development (2026–present), Wadhwani Innovation & Translation Center, IIT Bombay — previously Postdoc, Stanford University (2019); Research Scientist, IIT Delhi (2019–20); Postdoc, UT Southwestern Medical Center, USA (2021–25)
Ajay Kumar Yadav
Ph.D. student (2015-22) – Nepal
Title of the Thesis:
"Role of miRNAs and Glucose Metabolism in the Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma"

Postdoctoral Researcher (2022–present), Indiana University School of Medicine, Indianapolis — Dept. of Medical & Molecular Genetics (2022–Mar 2025), Dept. of Dermatology (Apr 2025–present)
Amit Kumar Mishra
Ph.D. student (2016-23) – India
Title of the Thesis:
"Identification and Characterization of Different HBV Interacting Host Proteins and Elucidation of their Mechanism of Action."

Postdoctoral Researcher (2023–present), Albert Einstein College of Medicine, New York, USA
Dr. Md. Musa Hossain
Ph.D. Student (2017–24) - india
Title of the Thesis:
“Role of Pyruvate Kinase M2 (PKM2) and DEAD-box Helicase 3 (DDX3) in the Progression of NAFLD”

Postdoctoral Researcher (2025–present), Dept. of Foundations of Medicine, NYU Grossman Long Island School of Medicine, USA
Dr. Amrendra Kumar Sah
Ph.D. Student (2018–25) – Nepal
Title of the Thesis:
"Role of Long Non-Coding RNAs in the Progression of NAFLD to Hepatocellular Carcinoma"

Project Research Scientist–II, South Asian University, New Delhi (current lab member) — previously Ex-Project Research Scientist–I, AIIMS, New Delhi
Dr. Sata Teja Naveen
Ph.D. Student (2019–25) – india
Title of the Thesis:
"Use of CRISPR/Cas Technology as a Diagnostic Platform and Experimental Therapeutic Strategy for Chronic Liver Disease"

PBST, CCMB Hyderabad (Aug 2025–Feb 2026)
Dr. Md. Ismail
Ph.D. Student (2020–26)– Bangladesh
Title of the Thesis:
"Study of the Role of Circular RNAs in the Survival of Hepatitis B Virus in Human Hepatic Cells"

PhD completed 2026

At the Bench

Beyond the Bench

SELECTED PUBLICATIONS

  • Pant K, et al. Butyrate induces ROS-mediated apoptosis and autophagy in hepatocellular carcinoma. PMID: 28600122
  • Pant K, et al. Butyrate inhibits SIRT-1 via miR-22 to trigger apoptosis in hepatic cells. PMID: 28288414
  • Pant K, et al. Butyrate-mediated SIRT-1 inhibition restricts HBV replication. PMID: 30501014
  • Gupta P, et al. ALR promotes liver regeneration via miR-26a/PTEN/p-Akt signalling. PMID: 31267617
  • Gupta P, et al. ALR inhibits TGF-β-induced hepatic fibrosis via miR-181a. PMID: 31166951
  • Yadav AK, et al. FFA-induced miR-181a-5p modulates apoptosis and proliferation in NAFLD. PMID: 35551953
  • Mishra AK, et al. BANF1 restricts HBV replication via HBx/miR-203 axis. PMID: 36519846
  • Mishra AK, et al. DDX3 restricts HBV via miR-34-mediated autophagy suppression. PMID: 36597176
  • Hossain MM, et al. PKM2 drives MASH progression; suppressed by miR-122. PMID: 39630362
  • Hossain MM, et al. DDX3/miR-141 inhibits SIRT1-mediated autophagy in MASLD. PMID: 39631458
  • Mishra AK, et al. ALR restricts HBV replication via ROS-mediated autophagy. PMID: 39934594
  • Ismail M, et al. circSETD2/miR-181a-5p axis promotes HBV replication via DDX3. PMID: 41484997
  • Naveen ST, et al. CRISPR/Cas13a-RPA platform for HBV/HCV diagnosis. PMID: 42289138
  • Naveen ST, et al. Protocol for producing miRNA mimics for functional studies. PMID: 40530509

Contact Us

We welcome enquiries from prospective PhD students, postdoctoral fellows and collaborators interested in liver biology, molecular virology and translational hepatology.

 

PRINCIPAL INVESTIGATOR        Prof. Senthil Kumar Venugopal

DEPARTMENT / UNIVERSITY     FLSB, South Asian University

EMAIL                                           drsenthil@sau.ac.in

ADDRESS                 LS-112, LSES Building, South Asian University, Rajpur road, Maidan Garhi, New Delhi-110068